Scarica l'app Stockscreener
2.88
7.10%
-0.22
Dopo l'orario di chiusura:
2.93
0.05
+1.74%
Precedente Chiudi:
$3.10
Aprire:
$3.15
Volume 24 ore:
3.85M
Relative Volume:
1.11
Capitalizzazione di mercato:
$666.59M
Reddito:
-
Utile/perdita netta:
$-179.82M
Rapporto P/E:
-2.1654
EPS:
-1.33
Flusso di cassa netto:
$-159.16M
1 W Prestazione:
-10.84%
1M Prestazione:
-3.68%
6M Prestazione:
+138.02%
1 anno Prestazione:
+196.91%
Intervallo 1D:
$2.85
$3.15
Intervallo di 1 settimana:
$2.85
$3.35
Portata 52W:
$0.76
$3.87
Gossamer Bio Inc Stock (GOSS) Company Profile
Nome
Gossamer Bio Inc
Settore
Industria
Telefono
(858) 684-1300
Indirizzo
3115 MERRYFIELD ROW, SAN DIEGO, CA
Confronta GOSS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
2.88 | 717.51M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-10 | Aggiornamento | UBS | Neutral → Buy |
| 2025-07-14 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-25 | Iniziato | Oppenheimer | Outperform |
| 2024-04-05 | Ripresa | Wedbush | Outperform |
| 2023-07-27 | Downgrade | UBS | Buy → Neutral |
| 2023-03-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-03-01 | Iniziato | Guggenheim | Neutral |
| 2022-12-07 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-12-07 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-12-07 | Downgrade | SMBC Nikko | Outperform → Neutral |
| 2022-10-20 | Iniziato | Goldman | Buy |
| 2022-09-21 | Iniziato | JP Morgan | Neutral |
| 2022-09-19 | Iniziato | Wedbush | Outperform |
| 2022-04-18 | Iniziato | Raymond James | Outperform |
| 2022-04-06 | Iniziato | UBS | Buy |
| 2022-01-10 | Aggiornamento | SMBC Nikko | Neutral → Outperform |
| 2021-11-09 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-09-21 | Ripresa | Piper Sandler | Overweight |
| 2020-06-29 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-22 | Iniziato | Piper Sandler | Overweight |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2019-12-03 | Ripresa | BofA/Merrill | Buy |
| 2019-10-30 | Iniziato | Berenberg | Buy |
| 2019-03-05 | Iniziato | Barclays | Overweight |
| 2019-03-05 | Iniziato | BofA/Merrill | Buy |
| 2019-03-05 | Iniziato | Evercore ISI | Outperform |
| 2019-03-05 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Gossamer Bio Inc Borsa (GOSS) Ultime notizie
The Truth About Gossamer Bio Inc (GOSS): Tiny Stock, Massive Drama – Is It Worth the Hype? - AD HOC NEWS
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 3.6%What's Next? - MarketBeat
Gossamer Bio Inc 4GB Stock Analysis and ForecastHigh Dividend Yield Stocks & Free Expert Stock Watchlists - earlytimes.in
Gossamer Bio (GOSS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Gossamer Bio: Market Moves and Future Prospects - StocksToTrade
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 4.1%Should You Sell? - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Shares Up 9.2%Here's Why - MarketBeat
Gossamer Bio, Inc.(NasdaqGS: GOSS) added to S&P Biotechnology Select Industry Index - marketscreener.com
Gap Down: Will Timberland Bancorp Inc stock outperform Nasdaq indexJuly 2025 Earnings & Low Volatility Stock Recommendations - moha.gov.vn
Gossamer Bio (GOSS) Sees Strong Analyst Confidence Amid Seralutinib Progress and Upcoming PROSERA Data - Finviz
Corient Private Wealth LLC Purchases 302,200 Shares of Gossamer Bio, Inc. $GOSS - MarketBeat
Aug Decliners: Can Gossamer Bio Inc. stock deliver surprise earnings beatWeekly Profit Recap & Expert Curated Trade Setups - Улправда
Is Gossamer Bio Inc. stock attractive for income investorsJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - DonanımHaber
Gossamer Bio: High Risk Binary Approaches (NASDAQ:GOSS) - Seeking Alpha
Will Gossamer Bio Inc. stock reach Wall Street targetsJuly 2025 Highlights & Low Risk High Reward Ideas - DonanımHaber
Gossamer Bio, Inc. (NASDAQ:GOSS) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Aug Swings: Can Gossamer Bio Inc. stock hit record highs againMarket Risk Report & Intraday High Probability Alerts - Улправда
Can Gossamer Bio Inc. stock deliver surprise earnings beatJuly 2025 Setups & Free Daily Entry Point Trade Alerts - Улправда
Gossamer Bio (NASDAQ:GOSS) Sets New 1-Year HighShould You Buy? - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 6.5%Time to Sell? - MarketBeat
Oppenheimer Confident in Positive PROSERA Trial Readout in February 2026 for Gossamer Bio (GOSS) - Finviz
Gossamer Bio Sees Unusually High Options Volume (NASDAQ:GOSS) - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Stock Price Up 5.1%Here's What Happened - MarketBeat
20 Stocks That Will Double in 2026 - Insider Monkey
Gossamer Bio (NASDAQ:GOSS) Hits New 52-Week HighShould You Buy? - MarketBeat
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)December 9, 2025 - BioSpace
Gossamer Bio announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Gossamer Bio Inc (GOSS) is looking forward to a strong quarter - setenews.com
Gossamer Bio (NASDAQ:GOSS) Stock Price Up 5.9%Still a Buy? - MarketBeat
Is Gossamer Bio Stock Built to Withstand a Pullback? - Trefis
What RSI levels show for Gossamer Bio Inc. (4GB) stockJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - Newser
Adversity is less terrifying than hope: Gossamer Bio Inc (GOSS) - setenews.com
Why millennials buy Gossamer Bio Inc. (4GB) stockJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Will Gossamer Bio Inc. stock maintain growth storyJuly 2025 Patterns & Community Supported Trade Ideas - Newser
How Recent Developments Are Shaping the Gossamer Bio Investment Story - Yahoo Finance
Gossamer Bio, Inc.'s (NASDAQ:GOSS) 28% Share Price Surge Not Quite Adding Up - simplywall.st
Gossamer Bio to Participate in Upcoming December 2025 Investor Conferences - BioSpace
Gossamer Bio to Participate in Upcoming Investor Conferences - Enidnews.com
Analysts Offer Predictions for Gossamer Bio FY2025 Earnings - MarketBeat
GOSS News Today | Why did Gossamer Bio stock go down today? - MarketBeat
How Gossamer Bio Inc. (4GB) stock reacts to fiscal policiesWeekly Trend Summary & Consistent Growth Equity Picks - newser.com
How Gossamer Bio Inc. (4GB) stock moves in volatile trading sessionsMarket Risk Analysis & Stock Portfolio Risk Management - newser.com
What downside risks could hit Gossamer Bio Inc. (4GB) stock2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
Volume spikes in Gossamer Bio Inc. stock – what they meanPortfolio Risk Summary & Accurate Trade Setup Notifications - newser.com
Strategies to average down on Gossamer Bio Inc.2025 Trading Recap & Long Hold Capital Preservation Tips - newser.com
Will Gossamer Bio Inc. stock benefit from sector rotationJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Gossamer Bio Inc Azioni (GOSS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):